Tonix’s Second GPO Agreement for TONMYA Signals a Market Access Inflection Point for Fibromyalgia Coverage
Tonix Pharmaceuticals secured a second GPO agreement June 1, 2026, expanding TONMYA commercial coverage to ~52M U.S. lives—10 months...
Tonix Pharmaceuticals secured a second GPO agreement June 1, 2026, expanding TONMYA commercial coverage to ~52M U.S. lives—10 months...